Uzm. Dr. Nurgül Özgür Yurttaş
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 publicationsSource: OpenAlex / PubMed MeSHView publications
CV
Education and experience
Experience
- ExperienceGaziosmanpaşa Hastanesimedicalpark.com.tr
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyHaematologymedicalpark.com.trFrom source
- Department name at the sourceHematoloji Polikliniğimedicalpark.com.trFrom source
- Institutionİstinye Üniversitesi Gaziosmanpaşa Hastanesimedicalpark.com.trFrom source
- Area of workLeukemia, Myelogenous, Chronic, BCR-ABL PositiveExtracted from 4 publications · Model version —From source
- Publications27 publicationsORCID, OpenAlexFrom source
- ORCID0000-0002-9028-3483ORCIDFrom source
- Last synchronised4 November 2026 20:53https://www.medicalpark.com.tr/hekimler/nurgul-ozgur-yurttasmedicalpark.com.tr
Scientific work
Publications on Leukemia, Myelogenous, Chronic, BCR-ABL Positive
-
Intravesical Allogeneic Platelet Concentrate for Refractory BK Virus-Associated Haemorrhagic Cystitis After Allogeneic Haematopoietic Stem Cell Transplantation
Journal of Clinical Medicine, 2026
DOI 10.3390/jcm15197407 PMID 42881869 Open-access full textSource: ORCID
-
Ineffectiveness of therapeutic plasma exchange as a last resort in severe COVID-19 cases: Experience from a tertiary intensive care unit
Therapeutic Apheresis and Dialysis, 2024
DOI 10.1111/1744-9987.14219 PMID 39425626 1 citation (Europe PMC) Source: ORCID
-
Entecavir‐induced neutropenia in an adult living donor liver transplant recipient: Successful conversion to tenofovir alafenamide
Clinical Case Reports, 2023
DOI 10.1002/ccr3.7741 PMID 37575459 1 citation (Europe PMC) Open-access full textSource: ORCID
-
Effect of Tyrosine Kinase Inhibitor Therapy on Estimated Glomerular Filtration Rate in Patients with Chronic Myeloid Leukemia
Clinical Lymphoma Myeloma & Leukemia, 2023
DOI 10.1016/j.clml.2023.12.004 PMID 38281820 5 citations (OpenAlex) Open-access full textSource: OpenAlex
-
Clinical Application of Biomarkers for Hematologic Malignancies
BENTHAM SCIENCE PUBLISHERS eBooks, 2022
DOI 10.2174/9789815040463122010010 Source: OpenAlex
-
Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center Experience
Clinical Lymphoma Myeloma & Leukemia, 2021
DOI 10.1016/j.clml.2021.04.005 PMID 34052176 6 citations (Europe PMC) Source: OpenAlex
-
Tocilizumab in COVID-19: The Cerrahpaşa-PREDICT score
Journal of Infection and Chemotherapy, 2021
DOI 10.1016/j.jiac.2021.05.007 PMID 34120824 8 citations (Europe PMC) Open-access full textSource: OpenAlex
-
Candida esophagitis incidentally detected by 18F‐FDG PET/CT in a patient with CNS lymphoma
Clinical Case Reports, 2021
DOI 10.1002/ccr3.4322 PMID 34084527 4 citations (OpenAlex) Open-access full textSource: OpenAlex
-
Follicular lymphoma generating in a patient with non-small cell lung cancer following nivolumab discontinuation
Journal of Oncology Pharmacy Practice, 2020
DOI 10.1177/1078155220918627 PMID 32299317 1 citation (Europe PMC) Source: OpenAlex
-
Novel therapeutic approaches in chronic myeloid leukemia
Leukemia Research, 2020
DOI 10.1016/j.leukres.2020.106337 PMID 32200189 44 citations (OpenAlex) Source: OpenAlex